XML 35 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1
Equity Compensation, Employment Agreements and Other Benefit Plans
12 Months Ended
Dec. 31, 2017
Compensation Related Costs [Abstract]  
Equity Compensation, Employment Agreements and Other Benefit Plans
Equity Compensation, Employment Agreements and Other Benefit Plans
 
(aEquity Compensation Plan
 
In accordance with the terms of the Company’s Equity Compensation Plan (the “Equity Plan”), which was adopted by the Company’s stockholders on May 21, 2015 (and which amended and restated the Company’s 2010 Equity Compensation Plan), directors, officers and employees of the Company and any of its subsidiaries and other persons expected to provide significant services for the Company and any of its subsidiaries are eligible to receive grants of stock options (“Options”), restricted stock, RSUs, dividend equivalent rights and other stock-based awards under the Equity Plan.

 Subject to certain exceptions, stock-based awards relating to a maximum of 12.0 million shares of common stock may be granted under the Equity Plan; forfeitures and/or awards that expire unexercised do not count towards this limit.  At December 31, 2017, approximately 6.7 million shares of common stock remained available for grant in connection with stock-based awards under the Equity Plan.  A participant may generally not receive stock-based awards in excess of 1.5 million shares of common stock in any one year and no award may be granted to any person who, assuming exercise of all Options and payment of all awards held by such person, would own or be deemed to own more than 9.8% of the outstanding shares of the Company’s common stock.  Unless previously terminated by the Board, awards may be granted under the Equity Plan until May 20, 2025.
 
Restricted Stock Units
 
Under the terms of the Equity Plan, RSUs are instruments that provide the holder with the right to receive, subject to the satisfaction of conditions set by the Compensation Committee of the Board (the “Compensation Committee”) at the time of grant, a payment of a specified value, which may be a share of the Company’s common stock, the fair market value of a share of the Company’s common stock, or such fair market value to the extent in excess of an established base value, on the applicable settlement date.  Although the Equity Plan permits the Company to issue RSUs that can settle in cash, all of the Company’s outstanding RSUs as of December 31, 2017 are designated to be settled in shares of the Company’s common stock.  All RSUs outstanding at December 31, 2017 may be entitled to receive dividend equivalent payments depending on the terms and conditions of the award either in cash at the time dividends are paid by the Company, or for certain performance-based RSU awards, as a grant of stock at the time such awards are settled. At December 31, 2017 and 2016, the Company had unrecognized compensation expense of $4.1 million and $3.6 million, respectively, related to RSUs.   The unrecognized compensation expense at December 31, 2017 is expected to be recognized over a weighted average period of 1.8 years
 
The following table presents information with respect to the Company’s RSUs during the years ended December 31, 2017, 2016 and 2015:
 
 
For the Year Ended December 31, 2017
 
RSUs With
Service
Condition
 
Weighted
Average
Grant Date
Fair Value
 
RSUs With
Market and
Service
Conditions
 
Weighted
Average
Grant Date
Fair Value
 
Total
RSUs
 
Total 
Weighted
Average 
Grant Date 
Fair Value
Outstanding at beginning of year:
1,194,299

 
$
7.38

 
863,800

 
$
5.45

 
2,058,099

 
$
6.57

Granted (1)
447,695

 
7.96

 
451,250

 
6.48

 
898,945

 
7.22

Settled
(616,966
)
 
7.32

 
(293,800
)
 
5.83

 
(910,766
)
 
6.84

Cancelled/forfeited

 

 

 

 

 

Outstanding at end of year
1,025,028

 
$
7.67

 
1,021,250

 
$
5.80

 
2,046,278

 
$
6.73

RSUs vested but not settled at end of year
586,419

 
$
7.98

 
275,000

 
$
5.73

 
861,419

 
$
7.26

RSUs unvested at end of year
438,609

 
$
7.25

 
746,250

 
$
5.82

 
1,184,859

 
$
6.35

 
 
For the Year Ended December 31, 2016
 
RSUs With
Service
Condition
 
Weighted
Average
Grant Date
Fair Value
 
RSUs With
Market and
Service
Conditions
 
Weighted
Average
Grant Date
Fair Value
 
Total
RSUs
 
Total 
Weighted
Average 
Grant Date 
Fair Value
Outstanding at beginning of year:
1,138,930

 
$
7.71

 
736,800

 
$
5.66

 
1,875,730

 
$
6.90

Granted (2)
420,695

 
6.81

 
307,500

 
4.81

 
728,195

 
5.96

Settled
(360,326
)
 
7.75

 
(175,500
)
 
5.21

 
(535,826
)
 
6.92

Cancelled/forfeited
(5,000
)
 
7.32

 
(5,000
)
 
5.27

 
(10,000
)
 
6.29

Outstanding at end of year
1,194,299

 
$
7.38

 
863,800

 
$
5.45

 
2,058,099

 
$
6.57

RSUs vested but not settled at end of year
617,518

 
$
7.45

 
293,800

 
$
5.83

 
911,318

 
$
6.93

RSUs unvested at end of year
576,781

 
$
7.30

 
570,000

 
$
5.25

 
1,146,781

 
$
6.28

 
 
For the Year Ended December 31, 2015
 
RSUs With
Service
Condition
 
Weighted
Average
Grant Date
Fair Value
 
RSUs With
Market and
Service
Conditions
 
Weighted
Average
Grant Date
Fair Value
 
Total
RSUs
 
Total 
Weighted
Average 
Grant Date 
Fair Value
Outstanding at beginning of year:
769,174

 
$
7.55

 
449,300

 
$
5.61

 
1,218,474

 
$
6.84

Granted (3)
390,804

 
7.96

 
291,250

 
5.73

 
682,054

 
7.01

Settled
(17,298
)
 
6.60

 

 

 
(17,298
)
 
6.60

Cancelled/forfeited
(3,750
)
 
7.97

 
(3,750
)
 
5.73

 
(7,500
)
 
6.85

Outstanding at end of year
1,138,930

 
$
7.71

 
736,800

 
$
5.66

 
1,875,730

 
$
6.90

RSUs vested but not settled at end of year
554,023

 
$
7.83

 
175,500

 
$
5.21

 
729,523

 
$
7.20

RSUs unvested at end of year
584,907

 
$
7.59

 
561,300

 
$
5.80

 
1,146,207

 
$
6.71


(1) The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs.  In determining the fair value for 758,750 of these awards granted in 2017, the Company applied:  (i) a weighted average volatility estimate of approximately 15%, which was determined considering historic volatility in the price of the Company’s and its peer group companies’ common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s and peer group companies’ common stock at the grant date; and (ii) a weighted average risk-free rate of 1.46% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards.  The weighted average grant date fair value for the remaining 140,195 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date of $8.31. There are no post vesting conditions on these awards.
(2) The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs.  In determining the fair value for 615,000 of these awards granted in 2016, the Company applied:  (i) a weighted average volatility estimate of approximately 17%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 1.20% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 11%.  The weighted average grant date fair value for the remaining 113,195 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date of $7.20. There are no post vesting conditions on these awards.
(3) The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs.  In determining the fair value for 582,500 of these awards granted in 2015, the Company applied:  (i) a weighted average volatility estimate of approximately 18%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 0.90% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 9%.  The weighted average grant date fair value for the remaining 99,554 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date ranging from $7.93 to $7.97. There are no post vesting conditions on these awards.

Restricted Stock
 
At December 31, 2017, the Company did not have any unvested shares of restricted common stock outstanding. At December 31, 2016, the Company had unrecognized compensation expense of approximately $203,000 and had accrued dividends payable of approximately $55,000 related to unvested shares of restricted stock, respectively.  The total fair value of restricted shares vested during the years ended December 31, 2017, 2016 and 2015 was approximately $2.0 million, $4.3 million and $4.3 million, respectively.

The following table presents information with respect to the Company’s restricted stock for the years ended December 31, 2017, 2016 and 2015:
 
 
For the Year Ended December 31,
 
2017
 
2016
 
2015
 
Shares of
Restricted
Stock
 
Weighted
Average
Grant Date
Fair Value (1)
 
Shares of
Restricted
Stock
 
Weighted
Average
Grant Date
Fair Value (1)
 
Shares of
Restricted
Stock
 
Weighted
Average
Grant Date
Fair Value (1)
Outstanding at beginning of year:
28,968

 
$
7.12

 
110,920

 
$
7.41

 
243,948

 
$
7.48

Granted
214,859

 
8.06

 
487,216

 
7.66

 
497,007

 
6.83

Vested (2)
(243,827
)
 
7.95

 
(567,851
)
 
7.64

 
(629,212
)
 
6.98

Cancelled/forfeited

 

 
(1,317
)
 
7.12

 
(823
)
 
7.74

Outstanding at end of year

 
$

 
28,968

 
$
7.12

 
110,920

 
$
7.41


(1) The grant date fair value of restricted stock awards is based on the closing market price of the Company’s common stock at the grant date.
(2) All restrictions associated with restricted stock are removed on vesting.

Dividend Equivalents
 
A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock. Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Equity Plan, and they are paid in cash or other consideration at such times and in accordance with such rules, as the Compensation Committee of the Board shall determine in its discretion.  Payments made on the Company’s outstanding dividend equivalent rights that have been granted as a separate instrument are charged to Stockholders’ Equity when common stock dividends are declared to the extent that such equivalents are expected to vest.  The Company did not make any payments in respect of such instruments during the year ended December 31, 2017 and made payments of approximately $5,000 and $16,000 during the years ended December 31, 2016 and 2015, respectively.
The following table presents information about the Company’s dividend equivalents rights awarded as separate instruments at and for each of the years ended December 31, 2016 and 2015. No such awards were granted during 2017:
 
 
 
For the Year Ended December 31,
 
 
2016
 
2015
 
 
Number of Dividend Equivalent Rights
Outstanding at beginning of year:
 
8,215

 
24,402

Granted
 

 

Cancelled, forfeited or expired
 
(8,215
)
 
(16,187
)
Outstanding at end of year
 

 
8,215



The weighted average grant date fair value of the dividend equivalent rights in the above table is $2.77. The determination of the weighted average grant date fair value of these awards required the Company to estimate certain valuation inputs.  In determining the fair value for these awards granted in 2011, the Company applied:  (i) a weighted average volatility estimate of approximately 31%, which was determined considering historic volatility in the price of Company’s common stock over the six-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 2.23% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 13%.
 
Options
 
The Company did not grant any stock options during the three years ended December 31, 2017. At December 31, 2017, the Company had no Options outstanding. 
  
Expense Recognized for Equity-Based Compensation Instruments
 
The following table presents the Company’s expenses related to its equity-based compensation instruments for the years ended December 31, 2017, 2016 and 2015:
 
 
 
For the Year Ended December 31,
(In Thousands)
 
2017
 
2016
 
2015
RSUs (1)
 
$
6,098

 
$
4,792

 
$
3,377

Restricted shares of common stock
 
1,935

 
4,326

 
4,373

Dividend equivalent rights
 

 
44

 
82

Total
 
$
8,033

 
$
9,162

 
$
7,832



(1) Equity-based compensation for the year ended December 31, 2017 includes a one-time expense of approximately $900,000 for the accelerated vesting of certain time-based equity awards arising from the death of the Company’s former Chief Executive Officer.

(bEmployment Agreements
 
At December 31, 2017, the Company had employment agreements with three of its officers, with varying terms that provide for, among other things, base salary, bonus and change-in-control payments upon the occurrence of certain triggering events.
 
(cDeferred Compensation Plans
 
The Company administers deferred compensation plans for its senior officers and non-employee directors (collectively, the “Deferred Plans”), pursuant to which participants may elect to defer up to 100% of certain cash compensation.  The Deferred Plans are designed to align participants’ interests with those of the Company’s stockholders.
 
Amounts deferred under the Deferred Plans are considered to be converted into “stock units” of the Company.  Stock units do not represent stock of the Company, but rather are a liability of the Company that changes in value as would equivalent shares of the Company’s common stock.  Deferred compensation liabilities are settled in cash at the termination of the deferral period, based on the value of the stock units at that time.  The Deferred Plans are non-qualified plans under the Employee Retirement Income Security Act of 1974 and, as such, are not funded.  Prior to the time that the deferred accounts are settled, participants are unsecured creditors of the Company.
 
The Company’s liability for stock units in the Deferred Plans is based on the market price of the Company’s common stock at the measurement date.  The following table presents the Company’s expenses related to its Deferred Plans for its non-employee directors and senior officers for the years ended December 31, 2017, 2016 and 2015:
 
 
 
For the Year Ended December 31,
(In Thousands)
 
2017
 
2016
 
2015
Non-employee directors
 
$
171

 
$
231

 
$
(59
)
Total
 
$
171

 
$
231

 
$
(59
)

 
The Company did not distribute cash to the participants of the Deferred Plans during the year ended December 31, 2017. The Company distributed cash of $122,000 and $109,000 to the participants of the Deferred Plans during the years ended December 31, 2016 and 2015, respectively.  The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through December 31, 2017 and 2016 that had not been distributed and the Company’s associated liability for such deferrals at December 31, 2017 and 2016:
 
 
 
December 31, 2017
 
December 31, 2016
(In Thousands)
 
Undistributed
Income
Deferred (1)
 
Liability Under
Deferred Plans
 
Undistributed
Income
Deferred (1)
 
Liability Under
Deferred Plans
Non-employee directors
 
$
1,688

 
$
2,056

 
$
1,066

 
$
1,263

Total
 
$
1,688

 
$
2,056

 
$
1,066

 
$
1,263


(1)  Represents the cumulative amounts that were deferred by participants through December 31, 2017 and 2016, which had not been distributed through such respective date.
 
(dSavings Plan
 
The Company sponsors a tax-qualified employee savings plan (the “Savings Plan”) in accordance with Section 401(k) of the Code.  Subject to certain restrictions, all of the Company’s employees are eligible to make tax deferred contributions to the Savings Plan subject to limitations under applicable law.  Participant’s accounts are self-directed and the Company bears the costs of administering the Savings Plan.  The Company matches 100% of the first 3% of eligible compensation deferred by employees and 50% of the next 2%, subject to a maximum as provided by the Code.  The Company has elected to operate the Savings Plan under the applicable safe harbor provisions of the Code, whereby among other things, the Company must make contributions for all participating employees and all matches contributed by the Company immediately vest 100%.  For the years ended December 31, 2017, 2016 and 2015, the Company recognized expenses for matching contributions of $363,000, $359,000 and $309,000, respectively.